2025-07-13 - Analysis Report
Okay, here's a report summarizing the provided data for Intuitive Surgical Inc. (ISRG), along with analysis.

## ISRG (Intuitive Surgical Inc) Stock Analysis

**Company Overview:** Intuitive Surgical Inc. is a global technology leader in robotic-assisted minimally invasive surgery.

### 1. Performance vs. S&P 500 (VOO)

*   **ISRG Cumulative Return:** 118.46%
*   **VOO Cumulative Return:** 95.46%
*   **Absolute Deviation:** 28.3
*   **Relative Deviation:** 26.1 (Positioned in the 26.1th percentile relative to the historical range of deviation). The stock is currently outperforming the S&P 500, but the relative deviation suggests it is in the lower range of its historical outperformance.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD      | Alpha   | Beta | Cap(B) |
|------------|---------|----------|---------|------|--------|
| 2015-2017  | 68.0%   | 56.5%    | 39.0%   | 0.0  | 43.6   |
| 2016-2018  | 77.0%   | 63.4%    | 59.0%   | 0.0  | 57.2   |
| 2017-2019  | 81.0%   | 63.4%    | 52.0%   | 0.3  | 70.6   |
| 2018-2020  | 47.0%   | 63.4%    | 28.0%   | 0.2  | 97.7   |
| 2019-2021  | 91.0%   | 63.0%    | 43.0%   | 0.2  | 128.8  |
| 2020-2022  | -3.0%   | 69.9%    | -6.0%   | 0.2  | 95.1   |
| 2021-2023  | -5.0%   | 72.9%    | -23.0%  | 0.9  | 120.9  |
| 2022-2024  | 26.0%   | 72.9%    | 0.0%    | 0.9  | 187.1  |
| 2023-2025  | 39.0%   | 72.9%    | -8.0%   | 0.7  | 183.5  |

**Analysis:**

*   **Strong Early Performance:** ISRG demonstrated impressive growth in the mid-2010s with high CAGRs and significant Alpha generation, showing outperformance relative to its risk-adjusted benchmark.  Beta values were relatively low, indicating lower market sensitivity.
*   **Recent Challenges:** The more recent periods (2020-2023) reveal negative CAGRs and negative Alpha, suggesting underperformance.  Beta increased, showing higher sensitivity to market movements.
*   **Volatility:** The Maximum Drawdown (MDD) figures are consistently high, indicating significant price volatility and potential risk.
*   **Market Cap Growth:** The company's market capitalization has generally increased over the periods, reflecting overall growth despite recent performance challenges.

### 2. Recent Price Action

*   **Last Price:** $512.06
*   **Previous Close:** $526.05
*   **Change:** -2.66% (Significantly down compared to the previous close, indicating a negative price movement.)
*   **5-Day Moving Average:** 525.65
*   **20-Day Moving Average:** 525.11
*   **60-Day Moving Average:** 530.12

**Analysis:**

*   The price is below all moving averages (5-day, 20-day, and 60-day), suggesting a short-term downtrend. The recent significant drop reinforces this bearish sentiment.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 51.58 (Neutral)
*   **PPO:** -0.19 (Slightly Bearish)
*   **Hybrid Signal:** "cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)" - Suggests a cautious buying opportunity, despite the MRI indicating low risk.
*   **Recent (20-day) Relative Deviation Change:** -6.6 (Decreasing - Short-term Decline)
*   **Expected Return (%):** 117.2% (Projected long-term outperformance vs. S&P 500)

**Analysis:**

*   While the MRI indicates low market risk, the PPO suggests a slightly bearish trend. The RSI is neutral, indicating neither overbought nor oversold conditions.
*   The negative change in relative deviation confirms the recent underperformance compared to the S&P 500.
*   The hybrid signal's caution suggests considering the recent negative price action and technical indicators despite the low-risk environment indicated by MRI.
*   The high expected return suggests significant long-term potential, but it should be considered in light of recent underperformance and volatility.

### 4. Recent News & Significant Events

*   **[2025-07-10]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-13]:** Analyst discussions of recent performance and outlook.
*   **[2025-07-09]:** Notable stock volatility influenced by news, earnings, or executive actions.
*   **[2025-07-11]:** Market experts highlighting risks and opportunities.

**Analysis:**

*   The recent news indicates volatility and significant events influencing the stock. Investors should closely monitor company announcements and industry trends.
*   Analyst discussions suggest a period of scrutiny and potentially mixed opinions on the company's prospects.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-04-23 | 1.95 | 2.25 B$    |
| 2024-10-18 | 1.59 | 2.04 B$    |
| 2024-07-19 | 1.48 | 2.01 B$    |
| 2024-04-19 | 1.54 | 1.89 B$    |
| 2025-04-23 | 1.54 | 1.89 B$    |

**Analysis:**

*   **Revenue Growth:**  The company has generally shown consistent revenue growth over the past year.
*   **EPS Improvement:** The EPS shows an upward trend, indicating improved profitability.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | \$2.25B   | 64.69%        |
| 2024-12-31 | \$2.41B   | 68.04%        |
| 2024-09-30 | \$2.04B   | 67.41%        |
| 2024-06-30 | \$2.01B   | 68.30%        |
| 2024-03-31 | \$1.89B   | 65.87%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE   |
|------------|-----------|-------|
| 2025-03-31 | \$17.11B  | 4.08% |
| 2024-12-31 | \$16.43B  | 4.17% |
| 2024-09-30 | \$15.58B  | 3.63% |
| 2024-06-30 | \$14.71B  | 3.58% |
| 2024-03-31 | \$13.96B  | 3.90% |

**Analysis:**

*   **Strong Revenue:** ISRG exhibits a solid revenue stream with consistent quarterly growth.
*   **High Profit Margins:** Profit margins remain high, generally above 65%, indicating efficient operations and pricing power.
*   **Growing Equity:**  The company's equity has been steadily increasing, reflecting healthy financial growth and retained earnings.
*   **Consistent ROE:** Return on Equity (ROE) is stable, suggesting consistent profitability relative to shareholder equity.

### 7. Overall Summary

Intuitive Surgical Inc. (ISRG) has demonstrated strong historical growth and profitability, but recent performance has lagged compared to the S&P 500. While the company maintains strong revenue and profit margins, recent news indicates volatility, and technical indicators suggest a short-term downtrend. The long-term expected return remains high, but investors should be cautious and monitor company announcements, analyst opinions, and industry trends. Consider the potential for a rebound given the strong fundamentals, but be aware of the inherent volatility.
